Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral

Anna Maria Sironi1, Alessandro Pingitore, Sergio Ghione

  • 1Metabolism and MRI Laboratory, Consiglio Nazionale delle Ricerche Institute of Clinical Physiology, Via Moruzzi, 1-S Cataldo, 56124 Pisa, Italy. sironi@ifc.cnr.it

Insights

Early hypertension reduces regional heart function, even with normal global cardiac performance. Insulin resistance, visceral fat, and dyslipidemia are linked to this decline.

Area of Science:

  • Cardiology
  • Metabolic Syndrome
  • Medical Imaging

Background:

  • Mild-to-moderate hypertension is frequently linked to insulin resistance and visceral adiposity.
  • The independent impact of these metabolic abnormalities on regional cardiac function remains unclear.

Purpose of the Study:

  • To investigate the effects of elevated blood pressure, insulin resistance, and ectopic fat on peak systolic circumferential strain.
  • To assess the relationship between these factors and regional cardiac function in men.

Main Methods:

  • Cardiac magnetic resonance (MR) imaging with tissue tagging was used to evaluate regional function.
  • MR imaging quantified abdominal visceral and epicardial fat.
  • Oral glucose tolerance tests assessed glucose tolerance and insulin resistance; serum lipid profiles were analyzed.

Main Results:

  • Circumferential shortening progressively decreased across blood pressure groups (normal, prehypertension, hypertension).
  • Reduced circumferential strain correlated with higher blood pressure, independent of age.
  • Strain reduction was also associated with epicardial/visceral fat, triglycerides, and insulin resistance, independent of age and blood pressure.

Conclusions:

  • Regional left ventricular function is impaired in early hypertension stages, despite normal global function.
  • Insulin resistance, dyslipidemia, and ectopic fat accumulation are associated with reduced regional systolic function.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...